CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Open-market sale Chief Medical Officer sold 5,035 shares at $5.56 ($27,995)
- 4 Gift Director gave 9,459 shares (gift)
- 4 Open-market sale Chief Executive Officer sold 23,831 shares at $5.56 ($132,500)
- 4 Open-market sale President and Head of R&D sold 12,519 shares at $5.56 ($69,606)
- 4 Grant or award Chief Medical Officer acquired 108,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 123,000 shares (grant or award)
- 4 Grant or award President and Head of R&D acquired 163,600 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 397,600 shares (grant or award)
- 4 Open-market sale 10% owner sold 500,000 shares at $6.00 ($3,000,000)
- 4 Open-market sale Director sold 500,000 shares at $6.00 ($3,000,000)
- 4 Open-market sale Chief Executive Officer sold 5,647 shares at $5.19 ($29,333)
- 4 Open-market sale President and Head of R&D sold 6,214 shares at $5.19 ($32,277)
- 4 Open-market sale Chief Medical Officer sold 2,771 shares at $5.19 ($14,393)
- 4 Open-market sale Chief Financial Officer sold 1,114 shares at $5.19 ($5,786)
- 4 Other disposition Director disposed of 598,533 shares (other)
- 4 Other disposition 10% owner disposed of 598,533 shares (other)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
Page 6 of 16 · 301 filings